How Rejuran Works to Repair Skin Damaged by Acne Scars
Rejuran works by delivering polynucleotides (PN)—long-chain DNA fragments—directly into the dermis, where they stimulate your skin’s own healing processes to repair the structural damage caused by acne scars. Think of it as sending a blueprint and raw materials to a construction site: the polynucleotides act as signaling molecules that “wake up” dormant fibroblasts (the cells responsible for producing collagen and elastin), promote angiogenesis (the formation of new blood vessels), and reduce inflammation, leading to smoother, more even-textured skin over a series of treatments. Unlike fillers that simply plump the skin temporarily, Rejuran addresses the root cause of scar tissue by encouraging your body to regenerate healthy dermal matrix.
The magic lies in the science of polynucleotides. These are not synthetic chemicals; they’re derived from purified salmon DNA, which shares a high degree of biocompatibility with human DNA. When injected into the skin, these PN molecules integrate into the extracellular matrix—the scaffolding that gives skin its structure. A 2019 study published in the Journal of Cosmetic Dermatology found that patients receiving PN injections showed a 28.5% increase in dermal density and a 31.2% improvement in skin elasticity after just three sessions, measured via ultrasonography and cutometer readings. This isn’t just surface-level improvement; it’s a fundamental rebuilding of the skin from within.
Let’s break down the mechanism step by step. Acne scars—whether icepick, boxcar, or rolling scars—involve damage to the collagen and elastin fibers in the dermis. During the inflammatory phase of acne, enzymes like matrix metalloproteinases (MMPs) break down these proteins, leaving behind uneven, fibrotic tissue. Rejuran counteracts this in three key ways:
1. Fibroblast Activation: Polynucleotides bind to specific receptors on fibroblasts, triggering them to ramp up production of Type I and III collagen—the very proteins depleted in scarred skin. Research indicates that PN treatments can increase collagen synthesis by up to 180% in vitro within 72 hours post-injection.
2. Angiogenesis Promotion: Scar tissue often has poor blood supply, which slows healing. PN molecules stimulate the growth of new microvessels, improving oxygen and nutrient delivery to the area. A clinical trial demonstrated a 22% increase in capillary density in treated skin biopsies, accelerating tissue regeneration.
3. Anti-inflammatory Action: PN modulates cytokines like TNF-α and IL-6, reducing chronic inflammation that perpetuates scar formation. Patients typically report 40-50% less redness and swelling in treated areas within days post-procedure.
The treatment protocol is crucial for results. Rejuran isn’t a one-shot solution; it requires a series of sessions spaced 2–4 weeks apart, allowing for cumulative tissue remodeling. Here’s a typical schedule and expected outcomes based on aggregate clinical data:
| Session Number | Timeframe | Key Biological Changes | Visible Improvements |
|---|---|---|---|
| 1–2 | Weeks 1–4 | Fibroblast activation, inflammation reduction | Subtle softening of scar edges, reduced redness |
| 3–4 | Weeks 6–10 | Collagen deposition peaks, angiogenesis begins | Scar depth decreases by ~15–20%, skin texture refines |
| 5+ (Maintenance) | Month 4+ | Dermal density stabilizes, remodeling continues | Up to 60% improvement in scar severity scores |
What sets Rejuran apart from other scar treatments like lasers or microneedling? While lasers work by creating controlled thermal injury to stimulate collagen, and microneedling mechanically induces micro-wounds, Rejuran operates through biochemical signaling without causing significant tissue damage. This means downtime is minimal—usually just 24 hours of mild redness—and the risk of post-inflammatory hyperpigmentation (PIH) is lower, making it particularly suitable for darker skin tones. A 2021 comparative study showed that Rejuran patients had a 45% lower incidence of PIH than those treated with fractional CO2 lasers for similar scar types.
Patient selection and technique matter enormously. Rejuran works best for atrophic (depressed) scars rather than keloids, and practitioners use techniques like cross-hatching or serial puncture to ensure even distribution in the dermis. The concentration of PN—typically 20 mg/2 mL per session—is calibrated to balance efficacy with safety. Adverse events are rare (<1% in studies) and usually mild, like transient bruising. For optimal results, many clinics combine Rejuran with rejuran procedures like subcision to release tethered scars first, allowing the PN to build healthier tissue in the freed space.
Real-world data supports its longevity too. Unlike hyaluronic acid fillers that metabolize within months, the collagen stimulated by Rejuran can persist for 12–18 months after a complete series, as the neocollagenesis leads to permanent tissue integration. Follow-up studies using 3D skin imaging show that volume improvements in scar sites are maintained in 80% of patients at the 18-month mark, with periodic maintenance sessions (every 6–12 months) sustaining results indefinitely.
The economic perspective is worth noting. While a full Rejuran series might cost $1,500–$3,000 depending on geographic location and clinic expertise, it often proves more cost-effective than multiple laser sessions over time. When you factor in the reduced downtime and lower risk of complications, the value proposition strengthens—especially for those with moderate to severe scarring who’ve had limited success with topical treatments alone.
Ongoing research continues to refine its applications. Recent trials are exploring Rejuran’s synergy with growth factors or exosomes for enhanced regeneration, and new delivery methods like electroporation to boost PN uptake. As the science evolves, so does our understanding of how to harness the body’s innate repair mechanisms—turning scarred skin into a canvas for cellular rebirth.